https://www.selleckchem.com/products/cia1.html
Five of 27 (18.5%) HPV tests were positive. Follow-up surgical specimens did not identify high-grade lesions. Unsatisfactory rates among FTM patients differed significantly from the atrophic group (P 0.05), while epithelial abnormality rates and HPV positivity did not (P 0.05). Most FTM Papanicolaou tests reviewed showed features of atrophy. FTM patients receiving androgen have high Papanicolaou test unsatisfactory rates secondary to atrophy. Epithelial abnormality and HPV rates do not differ significantly from atrophic cisgender
Like
Comment
Share
